Form 4: BioLife Solutions CFO Troy Wichterman Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Troy Wichterman, CFO of BioLife Solutions, sold shares of common stock in multiple transactions between July and September 2024 under pre-arranged 10b5-1 trading plans.
Summary
- Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported the sale of common stock in a series of transactions.
- These transactions occurred on July 11, 2024, August 21, 2024, and September 16, 2024.
- The sales were executed under Rule 10b5-1(c) trading plans adopted by Wichterman on various dates to cover tax withholding obligations related to the vesting of restricted stock.
- On July 11, 2024, 828 shares were sold at a price of $20.54 per share.
- On August 21, 2024, 142 shares were sold at $25.61 per share.
- On September 16, 2024, 611 shares were sold at $25.12 per share.
- Following these transactions, Wichterman directly owns 124,388 shares of BioLife Solutions Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting stock sales by an insider under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, as these transactions are often part of routine financial planning.
Industry Context
Sales by company insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The fact that the sales are for tax obligations related to vesting restricted stock is also a common practice.
Comparison to Industry Standards
- It's common for executives at publicly traded companies, including those in the biotech and life sciences sectors like BioLife Solutions, to utilize 10b5-1 trading plans.
- These plans are often implemented to diversify personal holdings or cover tax obligations related to equity compensation.
- Comparable companies such as Thermo Fisher Scientific, Danaher Corporation, and Sartorius also see insider transactions as part of their executive compensation and financial planning strategies.
- The amounts and frequencies of these transactions are generally in line with industry standards for executive compensation and stock ownership.
Stakeholder Impact
- The stock sales by the CFO could have a minor impact on shareholder sentiment, although the sales were conducted under a pre-arranged trading plan.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/09/2021 | Effective date of a Rule 10b5-1(c) trading plan adopted by the reporting person. |
| 01/03/2023 | Effective date of a Rule 10b5-1(c) trading plan adopted by the reporting person. |
| 02/24/2022 | Effective date of a Rule 10b5-1(c) trading plan adopted by the reporting person. |
| 07/11/2024 | Date of the first reported transaction: sale of 828 shares at $20.54. |
| 08/21/2024 | Date of the second reported transaction: sale of 142 shares at $25.61. |
| 09/16/2024 | Date of the third reported transaction: sale of 611 shares at $25.12. |
| 09/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.